Vitamin D 3 Supplementation: Comparison of 1000 IU and 2000 IU Dose in Healthy Individuals.
- Published in:
- Life (2075-1729), 2023, v. 13, n. 3, p. 808, doi. 10.3390/life13030808
- By:
- Publication type:
- Article
Works matching AU JIRASKO, MICHAL
Results: 6
1
2
iPSCs in Neurodegenerative Disorders: A Unique Platform for Clinical Research and Personalized Medicine.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 9, p. N.PAG, doi. 10.3390/jpm12091485
- By:
- Publication type:
- Article
3
Comparison of Vitamin D3 Supplementation Doses of 1,000, 2,000, 4,000 and 8,000 IU in Young Healthy Individuals.
- Published in:
- In Vivo, 2025, v. 39, n. 1, p. 452, doi. 10.21873/invivo.13848
- By:
- Publication type:
- Article
4
Glycoprofiling of proteins as prostate cancer biomarkers: A multinational population study.
- Published in:
- PLoS ONE, 2024, v. 19, n. 3, p. 1, doi. 10.1371/journal.pone.0300430
- By:
- Publication type:
- Article
5
Serum levels of prostate specific antigen, free PSA, [−2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy.
- Published in:
- Prostate, 2025, v. 85, n. 1, p. 65, doi. 10.1002/pros.24801
- By:
- Publication type:
- Article
6
Preanalytical stability of molecular forms of prostate-specific antigen in serum samples (PSA, free PSA, [-2]proPSA) and their impact on fPSA/tPSA ratio and PHI.
- Published in:
- Prostate, 2024, v. 84, n. 7, p. 656, doi. 10.1002/pros.24681
- By:
- Publication type:
- Article